Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RNAC compared with CNTB: revenue, margins and what each company keeps, and the suppliers and customers both name
RNAC
Cartesian Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
CNTB
Connect Biopharma Holdings Ltd
Change
Mkt cap
Revenue
Revenue
vs
Compare
RNAC
Cartesian Therapeutics, Inc.
vs
CNTB
Connect Biopharma Holdings Ltd
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
RNAC: latest quarter is a loss; flow not drawable. CNTB: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
RNAC, solid
CNTB, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only RNAC
8
BIIB
Biogen MA, Inc., or Biogen
supplier
—
National Institutes of Health
unlisted
supplier
—
Genovis AB (publ.)
unlisted
supplier
—
NCI
unlisted
supplier
4 more · RNAC chain
›
Shared
0
No disclosed counterparties: CNTB.
Only CNTB
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
RNAC
Cartesian Therapeutics, Inc.
Change
6.55
▼
−2.91%
· post 6.55
Mkt cap
$196.4M
Revenue
$78,000
Q1 FY26
Revenue
$3M
FY25
CNTB
Connect Biopharma Holdings Ltd
Change
0.83
▼
−0.99%
· post 0.80
Closed
Oct 30 '26
Mkt cap
$50.4M
Revenue
$3M
Q2 FY26
Revenue
—
vs
Compare
Closed
Oct 30 '26
RNAC
Cartesian Therapeutics, Inc.
vs
CNTB
Connect Biopharma Holdings Ltd
6.55
▼
−2.91%
post 6.55
Price
0.83
▼
−0.99%
post 0.80
$196.4M
Mkt cap
$50.4M
Q1 FY26
$78,000
Revenue
$3M
Q2 FY26
FY25
$3M
Revenue
—
Change
Change
RNAC
6.55
▼
−2.91%
vs
CNTB
0.83
▼
−0.99%
Closed
Oct 30 '26